The market shifted hard in early 2026. A wave of FDA warning letters went out to compounding pharmacies and telehealth platforms, Novo Nordisk settled with major providers in March, and several big names quietly dropped their compounded semaglutide programs in favor of branded medications. Eli Lilly introduced oral orforglipron through LillyDirect in approximately April at about $149 per month. The whole space reorganized in about 90 days. If you researched this in 2025, your notes are out of date.
I went through six platforms as someone with limited time for phone calls, waiting rooms, or insurance paperwork. Here is what I found.
What I Looked At
- Speed: How fast does a physician actually review the intake form?
- Pharmacy transparency: Is the dispensing lab named, certified, and trackable?
- Price clarity: No “starting at” traps that require five clicks to find the real number.
- Shipping logistics: Overnight, reliable, no excuses.
- Scope: Does the platform handle everything, or does it hand you off mid-process?
The Six Best GLP-1 Options for Busy Professionals
1. HealthRX
The thing that sets HealthRX apart before you even get to price is how little friction is in the process. You complete an online health assessment, a U.S. board-certified physician reviews it within roughly 24 hours, and the medication ships overnight at no extra charge to all 50 states. That is the whole workflow. No membership waitlists, no insurance authorization loops.
Compounded semaglutide starts around $99 per month. Compounded tirzepatide starts around $149. Those numbers are genuinely lower than most telehealth competitors, and the pricing is upfront. Medication is dispensed by Manifest Pharmacy in Greer, South Carolina, a 503A compounding facility operating under USP-797 standards with lot-to-door tracking. The platform carries LegitScript certification (certificate 50087439). Compounded medications carry a different regulatory standing than FDA-approved branded drugs, something HealthRX makes no effort to obscure. But for a professional who needs low cash cost, named pharmacy accountability, and overnight delivery to any state, this is the easiest yes on the list.
The clinical trial data it references: semaglutide showed roughly 15% average body weight reduction at 68 weeks in the STEP 1 trial; tirzepatide showed roughly 21% at 72 weeks in SURMOUNT-1. Those are trial results, not guarantees.
2. FormBlends
A particular type of buyer will find FormBlends the right fit. The platform also offers compounded GLP-1 medications under physician oversight through an FDA-registered 503A pharmacy, but it publishes per-product purity testing that most competitors simply do not show you. I mean named numbers: HPLC purity percentages, mass spectrometry identity confirmation, endotoxin and sterility data. If you want to see the lab documentation before injecting anything, this is the only service on this list that puts it in front of you without asking.
Cash pricing runs higher than HealthRX. Semaglutide is priced at roughly $299 per vial and tirzepatide at roughly $349. Shipping covers 47 states, not all 50. FormBlends also carries a broader catalog of peptides for recovery, cognitive support, and longevity under the same clinician model, which is useful if you want one provider for more than weight loss. It ranks below HealthRX here strictly on price and geographic reach. For the transparency-first buyer, it is worth serious consideration.
3. Mochi Health
Mochi uses board-certified obesity-medicine clinicians, which is a real differentiator from platforms that rely on general practitioners. Compounded semaglutide runs about $99 per month and tirzepatide around $199. The monitoring cadence is more involved than some cash-pay services, which some people want and some find burdensome.
4. Hims & Hers
When Novo Nordisk reached its settlement in March 2026, Hims & Hers shifted its GLP-1 program away from compounded options and toward branded medications. Injectable Wegovy is priced around $299 per month, Zepbound around $399, and oral options around $249. Pair insurance coverage with a manufacturer savings card and out-of-pocket costs can fall close to nothing. The name recognition and customer service infrastructure are real advantages for people who want a large, established platform.
5. Ro Body
Ro charges roughly $39 for the first month, then $74 to $149 monthly, with medication billed separately. The platform has a dedicated prior-authorization team and accepts insurance for branded medications. For professionals who have insurance and want someone else to fight that battle, Ro’s model is set up for it.
6. Henry Meds
Henry Meds is a cash-pay compounding option with fast shipping, typically 24 to 72 hours. First-month pricing lands around $179 to $249. The monitoring is lighter than Mochi or Calibrate, which suits someone who just wants the prescription filled quickly and plans to work with their own doctor for follow-up.
How to Choose
Monthly cost is not the right place to start. Begin with pharmacy transparency: do you know where your medication is made, and can you verify the facility’s certifications? Then look at your insurance situation. If you have coverage, Ro or Hims may get you to very low out-of-pocket costs on branded drugs. If you are paying cash, HealthRX’s per-month pricing is hard to beat without sacrificing pharmacy accountability. If published purity data matters to you more than price, FormBlends is the answer. If you want hands-on clinical coaching, Mochi or Calibrate fit better.
One honest note: all compounded medications carry different regulatory standing than FDA-approved branded drugs, and no telehealth service replaces a relationship with a physician who knows your full medical history.
Common Questions
Does it actually matter which compounding pharmacy a GLP-1 telehealth service uses?
Yes, more than most people realize. A 503A pharmacy like Manifest Pharmacy operates under USP-797 sterility standards and is subject to state board oversight. Knowing the facility name lets you verify its status independently. Platforms that refuse to name their pharmacy are giving you a reason to look elsewhere.
If my schedule is completely unpredictable, which of these services handles that best?
HealthRX is the clearest answer here. Physician review runs asynchronously within 24 hours, overnight shipping requires no scheduling, and there are no required check-in calls. You interact with the platform on your own time, which is the whole point for someone whose calendar is not their own.
How did the March 2026 Novo Nordisk settlement actually change what Hims and Ro can offer?
The settlement pushed platforms that had been dispensing compounded semaglutide toward branded options instead. Hims & Hers moved to Wegovy and Zepbound at higher price points. Ro leaned into its insurance prior-authorization infrastructure. Cash-pay platforms like HealthRX and Henry Meds were less directly affected because they operate through 503A pharmacies rather than relying on Novo Nordisk supply agreements.
Is FormBlends worth the higher price compared to HealthRX if I am just trying to lose weight efficiently?
Depends on what keeps you up at night. If you want documented proof that what is in the vial matches what the label says, FormBlends publishes HPLC purity data and mass spectrometry results that no other service on this list provides. If you trust a certified 503A facility and want to spend $99 instead of $299 per month, HealthRX is the more practical choice.
Can a busy professional realistically skip the clinical coaching that Mochi offers and still get good results?
Coaching matters more for some people than others. Mochi’s obesity-medicine clinicians add real value if you want titration guidance, side-effect management, and accountability built into the program. If you already have a primary care doctor who will handle follow-up and you just need the prescription filled and shipped, lighter-touch services like Henry Meds or HealthRX are sufficient for that narrower role.
Sources
- FDA warning letters to compounding facilities and telehealth platforms, early 2026 (FDA.gov enforcement actions)
- Novo Nordisk settlement announcement, March 9, 2026 (public company statement)
- STEP 1 clinical trial: Wilding et al., *New England Journal of Medicine*, 2021
- SURMOUNT-1 clinical trial: Jastreboff et al., *New England Journal of Medicine*, 2022
- LillyDirect orforglipron pricing and launch, April 2026 (Eli Lilly press release)
- LegitScript certification registry (legitscript.com, certificate 50087439)
